The generic ingredient in VICTOZA is liraglutide. Based on analysis by DrugPatentWatch, the earliest date for a generic version of VICTOZA is ⤷ Sign Up.
The case settlement would have put the generic Liraglutide launch date to December 2024. However, expanding the indications of Victoza to the
Generic Victoza Availability. Last updated on . Victoza is a brand name of liraglutide, approved by the FDA in the following formulation(s): VICTOZA (liraglutide - solution;subcutaneous) Manufacturer: NOVO NORDISK INC Approval date: Janu Strength(s): 18MG/3ML (6MG/ML) Has a generic version of Victoza been approved?
The generic ingredient in VICTOZA is liraglutide. There are seven drug Generic Name, Dosage, NDA, Approval Date, TE, Type, RLD, RS, Patent No. Patent
Information about the launch of generic Victoza. Effective on the date of launch, J, generic Victoza (liraglutide) is not covered on Humana's
The generic version of Victoza is expected to be available after J. This estimated date is primarily based on the expiration date of a key patent
Effective on the date of launch, J, generic Victoza (liraglutide) is not covered on Humana's Medicare Advantage prescription drug and Medicare Part
Generic Release Date: Victoza's generic launch date based on the last expiry date of its patents and exclusivities combined is estimated to be (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
The generic version of Victoza is expected to be available after J. This estimated date is primarily based on the expiration date of a key patent
Comments